Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lars Hendrik Müschen"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. Consequently, patients undergo a multidisciplinary treatment that often requires intensive use of medical resources. This study provides an estimate on the
Externí odkaz:
https://doaj.org/article/eb47ed587116481d85e8766c14fafb57
Autor:
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, Gerrit Machetanz, Marcel Naumann, Sergio Castro-Gomez
Publikováno v:
Cells, Vol 12, Iss 5, p 736 (2023)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of upper and lower motor neurons, resulting in progressive weakness of all voluntary muscles and eventual respiratory failure. Non-motor symptoms, such as
Externí odkaz:
https://doaj.org/article/acf4b0091a8b43b0a1ca1d9cbeadfd4f
Autor:
Lars Hendrik Müschen, Alma Osmanovic, Camilla Binz, Konstantin F. Jendretzky, Gresa Ranxha, Paul Bronzlik, Omar Abu-Fares, Flavia Wiehler, Nora Möhn, Martin W. Hümmert, Stefan Gingele, Friedrich Götz, Martin Stangel, Thomas Skripuletz, Olivia Schreiber-Katz, Susanne Petri
Publikováno v:
Brain Sciences, Vol 11, Iss 3, p 296 (2021)
Approval of nusinersen, an intrathecally administered antisense oligonucleotide, for the treatment of 5q-spinal muscular atrophy (SMA) marked the beginning of a new therapeutic era in neurological diseases. Changes in routine cerebrospinal fluid (CSF
Externí odkaz:
https://doaj.org/article/728a945366eb4726a2918792f555c347
Publikováno v:
Klinische Neurophysiologie. 53:48-58
Die Diagnose der Amyotrophen Lateralsklerose ist weiterhin eine Herausforderung. Sowohl die revidierten El-Escorial-Kriterien als auch die Awaji-Kriterien werden zum Teil in der klinischen Praxis genutzt, sind jedoch komplex und wenig sensitiv. Die n
Autor:
Sonja Körner, Markus Maximilian Koch, Lars Hendrik Müschen, Tabea Seeliger, Olivia Schreiber-Katz, Stefan Gingele, Martin Stangel, Reinhard Dengler, Susanne Petri, Thomas Skripuletz, Alma Osmanovic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0815ff9f88fbbf57f25e6f758388c602
https://www.ncbi.nlm.nih.gov/pubmed/36989565
https://www.ncbi.nlm.nih.gov/pubmed/36989565
Autor:
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, Gerrit Machetanz, Marcel Naumann, Sergio Castro-Gomez
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of upper and lower motor neurons, resulting in progressive weakness of all voluntary muscles and eventual respiratory failure. Non-motor symptoms, such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e9f5dfc9c834da28dc1da108b4b182
https://mediatum.ub.tum.de/doc/1704628/document.pdf
https://mediatum.ub.tum.de/doc/1704628/document.pdf